1
|
Lakio S, Smith DJ, Andrade G, Sandler N, Evans P, McDermott J, Roe C, Hӕggström E. Small is Powerful: Demonstration of the Impact of Nanoformed Piroxicam in a Controlled Clinical Study. Pharm Res 2023; 40:2317-2327. [PMID: 37910340 DOI: 10.1007/s11095-023-03624-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2022] [Accepted: 10/12/2023] [Indexed: 11/03/2023]
Abstract
PURPOSE New solutions are needed to enable the efficient use of poorly water-soluble drugs. Therefore, we aimed to demonstrate that decreasing particle size with a solution-to-particle method known as nanoforming can improve dissolution and thus bioavailability. METHODS Piroxicam, a poorly water-soluble non-steroidal anti-inflammatory drug (NSAID), was used as a model compound. A Quality-by-Design (QbD) approach was used to nanoform piroxicam and a design space was established. The pharmacokinetics of piroxicam nanoparticles were compared to two marketed products in a clinical trial. RESULTS Nanoformed tablets showed a 33% increase in exposure during the first hour after dosing (AUC0-1 h) compared with an immediate release tablet and was similar to a fast absorbing tablet incorporating complexation of piroxicam with β-cyclodextrin. CONCLUSIONS The results show that nanoforming enabled more rapid absorption in comparison to a typical marketed tablet and indicate that nanoforming is an alternative to complex formulation such as cyclodextrins based products. The study outcomes support the potential of nanoforming for producing fast-acting dosage forms of poorly soluble drugs.
Collapse
Affiliation(s)
- Satu Lakio
- Nanoform Finland Plc, Viikinkaari 4, 00790, Helsinki, Finland.
- School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
| | - David J Smith
- Nanoform Finland Plc, Viikinkaari 4, 00790, Helsinki, Finland
| | - Goncalo Andrade
- Nanoform Finland Plc, Viikinkaari 4, 00790, Helsinki, Finland
| | - Niklas Sandler
- Nanoform Finland Plc, Viikinkaari 4, 00790, Helsinki, Finland
| | | | | | | | | |
Collapse
|
2
|
Comparison of the Dissolution Profiles and Polymorph Study of Four Commercially Available Piroxicam Tablets. Pharm Chem J 2022. [DOI: 10.1007/s11094-022-02780-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
3
|
Upadhyay P, Mishra MK, Ramamurty U, Bond AD. Mechanical Anisotropy and Tabletability of Famotidine Polymorphs. CrystEngComm 2022. [DOI: 10.1039/d1ce01406d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
In the drug development process, early characterization of solid forms can help to envisage the bulk processability of a powder, which should assist in selecting an optimal solid form. In...
Collapse
|
4
|
Garg U, Azim Y. Challenges and opportunities of pharmaceutical cocrystals: a focused review on non-steroidal anti-inflammatory drugs. RSC Med Chem 2021; 12:705-721. [PMID: 34124670 PMCID: PMC8152597 DOI: 10.1039/d0md00400f] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2020] [Accepted: 01/22/2021] [Indexed: 01/14/2023] Open
Abstract
The focus of the review is to discuss the relevant and essential aspects of pharmaceutical cocrystals in both academia and industry with an emphasis on non-steroidal anti-inflammatory drugs (NSAIDs). Although cocrystals have been prepared for a plethora of drugs, NSAID cocrystals are focused due to their humongous application in different fields of medication such as antipyretic, anti-inflammatory, analgesic, antiplatelet, antitumor, and anti-carcinogenic drugs. The highlights of the review are (a) background of cocrystals and other solid forms of an active pharmaceutical ingredient (API) based on the principles of crystal engineering, (b) why cocrystals are an excellent opportunity in the pharma industry, (c) common methods of preparation of cocrystals from the lab scale to bulk quantity, (d) some latest case studies of NSAIDs which have shown better physicochemical properties for example; mechanical properties (tabletability), hydration, solubility, bioavailability, and permeability, and (e) latest guidelines of the US FDA and EMA opening new opportunities and challenges.
Collapse
Affiliation(s)
- Utsav Garg
- Department of Applied Chemistry, Zakir Husain College of Engineering & Technology, Faculty of Engineering & Technology, Aligarh Muslim University Aligarh 202002 Uttar Pradesh India
| | - Yasser Azim
- Department of Applied Chemistry, Zakir Husain College of Engineering & Technology, Faculty of Engineering & Technology, Aligarh Muslim University Aligarh 202002 Uttar Pradesh India
| |
Collapse
|
5
|
Robert C, Fraser-Miller SJ, Be Rziņš KR, Okeyo PO, Rantanen J, Rades T, Gordon KC. Monitoring the Isothermal Dehydration of Crystalline Hydrates Using Low-Frequency Raman Spectroscopy. Mol Pharm 2021; 18:1264-1276. [PMID: 33406363 DOI: 10.1021/acs.molpharmaceut.0c01126] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Detection of the solid-state forms of pharmaceutical compounds is important from the drug performance point of view. Low-frequency Raman (LFR) spectroscopy has been demonstrated to be very sensitive in detecting the different solid-state forms of pharmaceutically relevant compounds. The potential of LFR spectroscopy to probe the in situ isothermal dehydration was studied using piroxicam monohydrate (PXM) and theophylline monohydrate (TPMH) as the model drugs. The dehydration of PXM and TPMH at four different temperatures (95, 100, 105, and 110 °C and 50, 60, 70, and 80 °C, respectively) was monitored in both the low- (20-300 cm-1) and mid-frequency (335-1800 cm-1) regions of the Raman spectra. Principal component analysis and multivariate curve resolution were applied for the analysis of the Raman data. Spectral differences observed in both regions highlighted the formation of specific anhydrous forms of piroxicam and theophylline from their respective monohydrates. The formation of the anhydrous forms was detected on different timescales (approx. 2 min) between the low and mid-frequency Raman regions. This finding highlights the differing nature of the vibrations being detected between these two spectral regions. Computational simulations performed were also in agreement with the experimental results, and allowed elucidating the origin of different spectral features.
Collapse
Affiliation(s)
- Chima Robert
- Dodd Walls Centre for Photonics and Quantum Technologies, University of Otago, 9016 Dunedin, New Zealand
| | - Sara J Fraser-Miller
- Dodd Walls Centre for Photonics and Quantum Technologies, University of Otago, 9016 Dunedin, New Zealand
| | - Ka Rlis Be Rziņš
- Dodd Walls Centre for Photonics and Quantum Technologies, University of Otago, 9016 Dunedin, New Zealand
| | - Peter O Okeyo
- Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.,The Danish National Research Foundation and Villum Foundation's Center for Intelligent Drug Delivery and Sensing Using Microcontainers and Nanomechanics (IDUN), Department of Health Technology, Technical University of Denmark, Ørsted Plads, 2800 Kgs Lyngby, Denmark
| | - Jukka Rantanen
- Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark
| | - Thomas Rades
- Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark
| | - Keith C Gordon
- Dodd Walls Centre for Photonics and Quantum Technologies, University of Otago, 9016 Dunedin, New Zealand
| |
Collapse
|
6
|
Upadhyay PP, Mishra MK, Ramamurty U, Bond AD. Structure–property correlations in piracetam polytypes. CrystEngComm 2021. [DOI: 10.1039/d0ce01694b] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Analysis of piracetam polytypes using energy-vector models, thermal expansion and nanoindentation measurements, produces a plausible link between their crystal structures and tableting behaviour.
Collapse
Affiliation(s)
| | - Manish Kumar Mishra
- Department of Pharmaceutics
- College of Pharmacy
- University of Minnesota
- Minneapolis
- USA
| | - Upadrasta Ramamurty
- School of Mechanical and Aerospace Engineering
- Nanyang Technological University
- Singapore 639798
- Republic of Singapore
- Institute of Materials Research and Engineering
| | | |
Collapse
|
7
|
Mazurek AH, Szeleszczuk Ł, Pisklak DM. Periodic DFT Calculations-Review of Applications in the Pharmaceutical Sciences. Pharmaceutics 2020; 12:E415. [PMID: 32369915 PMCID: PMC7284980 DOI: 10.3390/pharmaceutics12050415] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2020] [Revised: 04/28/2020] [Accepted: 04/29/2020] [Indexed: 12/31/2022] Open
Abstract
In the introduction to this review the complex chemistry of solid-state pharmaceutical compounds is summarized. It is also explained why the density functional theory (DFT) periodic calculations became recently so popular in studying the solid APIs (active pharmaceutical ingredients). Further, the most popular programs enabling DFT periodic calculations are presented and compared. Subsequently, on the large number of examples, the applications of such calculations in pharmaceutical sciences are discussed. The mentioned topics include, among others, validation of the experimentally obtained crystal structures and crystal structure prediction, insight into crystallization and solvation processes, development of new polymorph synthesis ways, and formulation techniques as well as application of the periodic DFT calculations in the drug analysis.
Collapse
Affiliation(s)
| | - Łukasz Szeleszczuk
- Chair and Department of Physical Pharmacy and Bioanalysis, Department of Physical Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 str., 02-093 Warsaw, Poland; (A.H.M.); (D.M.P.)
| | | |
Collapse
|
8
|
Crystal Growth in Gels from the Mechanisms of Crystal Growth to Control of Polymorphism: New Trends on Theoretical and Experimental Aspects. CRYSTALS 2019. [DOI: 10.3390/cryst9090443] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
A gel can be considered to be a two-phase (liquid and solid) system, which lacks flow once it reaches a stationary state. The solid phase is usually a tridimensional polymeric mesh, while the liquid phase is usually found in three forms: contained in great cavities, retained in the capillary pores between micelles, or adsorbed on the surface of a micelle. The influence of the use of gels in crystal growth is diverse and depends on the type of gel being used. A decrease in solubility of any solute in the liquid may occur if the solvent interacts extensively with the polymeric section, hence, the nucleation in gels in these cases apparently occurs at relatively low supersaturations. However, if the pore size is small enough, there is a possibility that a higher supersaturation is needed, due to the compartmentalization of solvents. Finally, this may also represent an effect in the diffusion of substances. This review is divided into three main parts; the first evaluates the theory and practice used for the obtainment of polymorphs. The second part describes the use of gels into crystallogenesis of different substances. The last part is related to the particularities of protein crystal polymorphism, as well as modern trends in gel growth for high-resolution X-ray crystallography.
Collapse
|
9
|
Song Q, Guo X, Sun Y, Yang M. Anti-solvent Precipitation Method Coupled Electrospinning Process to Produce Poorly Water-Soluble Drug-Loaded Orodispersible Films. AAPS PharmSciTech 2019; 20:273. [PMID: 31385126 DOI: 10.1208/s12249-019-1464-2] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2018] [Accepted: 06/24/2019] [Indexed: 01/27/2023] Open
Abstract
Orodispersible films (ODFs) are more convenient for paediatric and geriatric patients to take as compared to conventional tablets and capsules. Electrospinning has recently been attempted to produce ODFs. This study investigated the feasibility of formulating poorly water-soluble drug into ODFs using electrospinning technology coupled with the anti-solvent precipitation method. Piroxicam (PX), a poorly water-soluble drug, was chosen as a model drug. Polyvinyl alcohol and polyvinylpyrrolidone were used as film forming polymers. PX microcrystals were prepared using poloxamer as the stabilizer with the anti-solvent precipitation method, and then loaded in ODFs through the electrospinning process. The obtained ODFs were characterized using a scanning electron microscope, X-ray powder diffraction and Fourier transform infrared spectroscopy with respect to the morphology, solid state and potential molecular interaction between the model drug and polymers. The mechanical property, disintegration and dissolution rate of the obtained ODF were evaluated using dynamic mechanical analysis, a customized method and USP2 apparatus. The results showed that PX microcrystals suspended in polymeric solutions could be readily electrospun into fibrous films, where the microcrystals scattered between the fibers. The electrospun fibrous film-based ODFs exhibited satisfactory mechanical behaviour, and fast disintegration upon the polymer selection. In the dissolution tests, almost 90% of PX was dissolved within 6 min from the ODFs, whereas 40% of PX dissolved from physical mixtures in 60 min. This study demonstrated that poorly water-soluble drugs could be formulated into ODFs with satisfactory quality attributes by combining micronization and the electrospinning process.
Collapse
|
10
|
Liu X, Michalchuk AAL, Pulham CR, Boldyreva EV. An acetonitrile-solvated cocrystal of piroxicam and succinic acid with co-existing zwitterionic and non-ionized piroxicam molecules. ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY 2019; 75:29-37. [PMID: 30601128 DOI: 10.1107/s2053229618016911] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/05/2018] [Accepted: 11/28/2018] [Indexed: 11/10/2022]
Abstract
This work reports a new acetonitrile (ACN)-solvated cocrystal of piroxicam (PRX) and succinic acid (SA), 2C15H13N3O4S·0.5C4H6O4·C2H3N or PRX:SA:ACN (4:1:2), which adopts the triclinic space group P-1. The outcome of crystallization from ACN solution can be controlled by varying only the PRX:SA ratio, with a higher PRX:SA ratio in solution unexpectedly favouring a lower stoichiometric ratio in the solid product. In the new solvate, zwitterionic (Z) and non-ionized (NI) PRX molecules co-exist in the asymmetric unit. In contrast, the nonsolvated PRX-SA cocrystal contains only NI-type PRX molecules. The ACN molecule entrapped in PRX-SA·ACN does not form any hydrogen bonds with the surrounding molecules. In the solvated cocrystal, Z-type molecules form dimers linked by intermolecular N-H...O hydrogen bonds, whereas every pair of NI-type molecules is linked to SA via N-H...O and O-H...N hydrogen bonds. Thermogravimetry and differential scanning calorimetry suggest that thermal desolvation of the solvate sample occurs at 148 °C, and is followed by recrystallization, presumably of a multicomponent PRX-SA structure. Vibrational spectra (IR and Raman spectroscopy) of PRX-SA·ACN and PRX-SA are also used to demonstrate the ability of spectroscopic techniques to distinguish between NI- and Z-type PRX molecules in the solid state. Hence, vibrational spectroscopy can be used to distinguish the PRX-SA cocrystal and its ACN solvate.
Collapse
Affiliation(s)
- Xiaojiao Liu
- EaStCHEM School of Chemistry and Centre for Science at Extreme Conditions, University of Edinburgh, Joseph Black Building, Edinburgh EH9 3FJ, Scotland
| | - Adam A L Michalchuk
- EaStCHEM School of Chemistry and Centre for Science at Extreme Conditions, University of Edinburgh, Joseph Black Building, Edinburgh EH9 3FJ, Scotland
| | - Colin R Pulham
- EaStCHEM School of Chemistry and Centre for Science at Extreme Conditions, University of Edinburgh, Joseph Black Building, Edinburgh EH9 3FJ, Scotland
| | - Elena V Boldyreva
- Boreskov Institute of Catalysis, Siberian Branch of Russian Academy of Sciences, pr. Lavrentieva 5, Novosibirisk 630090, Russian Federation
| |
Collapse
|
11
|
Li D, Li J, Deng Z, Zhang H. Piroxicam–clonixin drug–drug cocrystal solvates with enhanced hydration stability. CrystEngComm 2019. [DOI: 10.1039/c9ce00666d] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Piroxicam and clonixin can form drug–drug crystalline complexes with the help of suitable solvent molecules.
Collapse
Affiliation(s)
- Duanxiu Li
- Laboratory of Magnetic Resonance Spectroscopy and Imaging
- Suzhou Institute of Nano-Tech and Nano-Bionics
- Chinese Academy of Sciences
- Suzhou 215123
- P. R. China
| | - Jiong Li
- CAS Key Laboratory of Nano-Bio Interface
- Suzhou Institute of Nano-Tech and Nano-Bionics
- Chinese Academy of Sciences
- Suzhou 215123
- P. R. China
| | - Zongwu Deng
- Laboratory of Magnetic Resonance Spectroscopy and Imaging
- Suzhou Institute of Nano-Tech and Nano-Bionics
- Chinese Academy of Sciences
- Suzhou 215123
- P. R. China
| | - Hailu Zhang
- Laboratory of Magnetic Resonance Spectroscopy and Imaging
- Suzhou Institute of Nano-Tech and Nano-Bionics
- Chinese Academy of Sciences
- Suzhou 215123
- P. R. China
| |
Collapse
|
12
|
Upadhyay PP, Pudasaini N, Mishra MK, Ramamurty U, Rantanen J. Early assessment of bulk powder processability as a part of solid form screening. Chem Eng Res Des 2018. [DOI: 10.1016/j.cherd.2018.05.020] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
13
|
Wu W, Löbmann K, Schnitzkewitz J, Knuhtsen A, Pedersen DS, Grohganz H, Rades T. Aspartame as a co-former in co-amorphous systems. Int J Pharm 2018; 549:380-387. [PMID: 30075253 DOI: 10.1016/j.ijpharm.2018.07.063] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2018] [Revised: 07/26/2018] [Accepted: 07/27/2018] [Indexed: 11/26/2022]
Abstract
Co-amorphous drug delivery systems are a promising approach to improve the dissolution rate and therefore potentially the oral bioavailability of poorly-water soluble drugs. Several low molecular weight excipients, for instance amino acids, have previously been shown to stabilize the amorphous form and increase the dissolution rate of drugs. In this study, the feasibility of aspartame, a methyl ester of the aspartic acid-phenylalanine dipeptide, as a co-former was investigated and compared with the respective single amino acids, both alone and in combination. The poorly water-soluble compounds mebendazole, tadalafil and piroxicam were chosen as model drugs. In contrast to the single amino acids or the physical mixture of both, all drug-aspartame mixtures became amorphous upon 90 min of ball milling. Only a single glass transition temperature (Tg) was detected by modulated differential scanning calorimetry, which indicates that a homogeneous single-phase co-amorphous system was obtained. Powder dissolution tests showed that the dissolution rates of the drugs from drug-aspartame co-amorphous samples were increased compared to crystalline drugs. Furthermore, supersaturation was observed for the mebendazole-aspartame and tadalafil-aspartame co-amorphous systems. In conclusion, aspartame has been shown to be a promising co-former in co-amorphous systems, superior to the single amino acids or their mixtures.
Collapse
Affiliation(s)
- Wenqi Wu
- Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark
| | - Korbinian Löbmann
- Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark
| | - Jan Schnitzkewitz
- Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark
| | - Astrid Knuhtsen
- Department of Drug Design and Pharmacology, University of Copenhagen, Denmark
| | | | - Holger Grohganz
- Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark.
| | - Thomas Rades
- Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark
| |
Collapse
|
14
|
Upadhyay PP, Sun CC, Bond AD. Relating the tableting behavior of piroxicam polytypes to their crystal structures using energy-vector models. Int J Pharm 2018; 543:46-51. [PMID: 29588210 DOI: 10.1016/j.ijpharm.2018.03.040] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2018] [Revised: 03/19/2018] [Accepted: 03/23/2018] [Indexed: 11/28/2022]
Abstract
Piroxicam crystallises into two polytypes, α1 and α2, with crystal structures that contain identical molecular layers but differ in the way that these layers are stacked. In spite of having close structural similarity, the polytypes have significantly different powder tabletting behaviour: α2 forms only weak tablets at low pressures accompanied by extensive capping and lamination, which make it impossible to form intact tablets above 100 MPa, while α1 exhibits superior tabletability over the investigated pressure range (up to 140 MPa). The potential structural origin of the different behaviour is sought using energy-vector models, produced from pairwise intermolecular interaction energies calculated using the PIXEL method. The analysis reveals that the most stabilising intermolecular interactions define columns in both crystal structures. In α2, a strongly stabilising interaction between inversion-related molecules links these columns into a 2-D network, while no comparable interaction exists in α1. The higher dimensionality of the energy-vector model in α2 may be one contributor to its inferior tabletability. A consideration of probable slip planes in the structures identifies regions where the benzothiazine groups of the molecules meet. The energy-vector models in this region are geometrically similar for both structures, but the interactions are more stabilising in α2 compared to α1. This feature may also contribute to the inferior tabletability of α2.
Collapse
Affiliation(s)
- Pratik P Upadhyay
- Department of Pharmacy, University of Copenhagen, 2100 Copenhagen Ø, Denmark
| | - Changquan C Sun
- Department of Pharmaceutics, University of Minnesota, Minneapolis, MN 55455, USA.
| | - Andrew D Bond
- Department of Pharmacy, University of Copenhagen, 2100 Copenhagen Ø, Denmark; Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK.
| |
Collapse
|
15
|
Persson AS, Ahmed H, Velaga S, Alderborn G. Powder Compression Properties of Paracetamol, Paracetamol Hydrochloride, and Paracetamol Cocrystals and Coformers. J Pharm Sci 2018; 107:1920-1927. [PMID: 29614273 DOI: 10.1016/j.xphs.2018.03.020] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2017] [Revised: 02/26/2018] [Accepted: 03/22/2018] [Indexed: 11/17/2022]
Abstract
The objective was to study the relationship between crystal structure, particle deformation properties, and tablet-forming ability for the monoclinic form of paracetamol (PRA), 2 cocrystals and a salt crystal of PRA in addition to 2 coformers (oxalic acid and 4,4'-bipyridine). Thus, the structure-property-performance relationship was investigated. Analytical powder compression was used for determination of effective plasticity, as inferred from the Heckel yield pressure and the Frenning parameter, and the elastic deformation was determined from in-die tablet elastic recovery. The plasticity could not be linked to the crystal lattice structure as crystals containing zig-zag layers displayed similar plasticity as crystals containing slip planes. In addition, crystals containing slip planes displayed both high and low plasticity. The mechanical properties could not be linked to the tablet-forming ability as the tablet tensile strength, unexpectedly, displayed a tendency to reduce with increased plasticity. Furthermore, the elastic deformation could not explain the tablet-forming ability. It was concluded that no relationship between structure-property-performance for PRA and its cocrystals and salt could be established. Thus, it was indicated that to establish such a relationship, an improved knowledge of crystallographic structure and interparticle bonding during compaction is needed.
Collapse
Affiliation(s)
- Ann-Sofie Persson
- Department of Pharmacy, Uppsala University, SE-751 23 Uppsala, Sweden.
| | - Hamzah Ahmed
- Pharmaceutical Research, Department of Health Sciences, Luleå University of Technology, SE-971 87 Luleå, Sweden
| | - Sitaram Velaga
- Pharmaceutical Research, Department of Health Sciences, Luleå University of Technology, SE-971 87 Luleå, Sweden
| | - Göran Alderborn
- Department of Pharmacy, Uppsala University, SE-751 23 Uppsala, Sweden
| |
Collapse
|
16
|
Lipiäinen T, Pessi J, Movahedi P, Koivistoinen J, Kurki L, Tenhunen M, Yliruusi J, Juppo AM, Heikkonen J, Pahikkala T, Strachan CJ. Time-Gated Raman Spectroscopy for Quantitative Determination of Solid-State Forms of Fluorescent Pharmaceuticals. Anal Chem 2018; 90:4832-4839. [PMID: 29513001 PMCID: PMC6150637 DOI: 10.1021/acs.analchem.8b00298] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2018] [Accepted: 03/07/2018] [Indexed: 11/29/2022]
Abstract
Raman spectroscopy is widely used for quantitative pharmaceutical analysis, but a common obstacle to its use is sample fluorescence masking the Raman signal. Time-gating provides an instrument-based method for rejecting fluorescence through temporal resolution of the spectral signal and allows Raman spectra of fluorescent materials to be obtained. An additional practical advantage is that analysis is possible in ambient lighting. This study assesses the efficacy of time-gated Raman spectroscopy for the quantitative measurement of fluorescent pharmaceuticals. Time-gated Raman spectroscopy with a 128 × (2) × 4 CMOS SPAD detector was applied for quantitative analysis of ternary mixtures of solid-state forms of the model drug, piroxicam (PRX). Partial least-squares (PLS) regression allowed quantification, with Raman-active time domain selection (based on visual inspection) improving performance. Model performance was further improved by using kernel-based regularized least-squares (RLS) regression with greedy feature selection in which the data use in both the Raman shift and time dimensions was statistically optimized. Overall, time-gated Raman spectroscopy, especially with optimized data analysis in both the spectral and time dimensions, shows potential for sensitive and relatively routine quantitative analysis of photoluminescent pharmaceuticals during drug development and manufacturing.
Collapse
Affiliation(s)
- Tiina Lipiäinen
- Division of Pharmaceutical
Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, FI-00790 Helsinki, Finland
| | - Jenni Pessi
- Division of Pharmaceutical
Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, FI-00790 Helsinki, Finland
| | - Parisa Movahedi
- Department of Future
Technologies, University of Turku, Vesilinnantie 5, FI-20500 Turku, Finland
| | - Juha Koivistoinen
- Nanoscience Center, Department of Chemistry, University of Jyväskylä, P.O. Box 35, FI-40014, Jyväskylä, Finland
| | - Lauri Kurki
- TimeGate Instruments, Teknologiantie 5, FI-90590 Oulu, Finland
| | - Mari Tenhunen
- TimeGate Instruments, Teknologiantie 5, FI-90590 Oulu, Finland
| | - Jouko Yliruusi
- Division of Pharmaceutical
Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, FI-00790 Helsinki, Finland
| | - Anne M. Juppo
- Division of Pharmaceutical
Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, FI-00790 Helsinki, Finland
| | - Jukka Heikkonen
- Department of Future
Technologies, University of Turku, Vesilinnantie 5, FI-20500 Turku, Finland
| | - Tapio Pahikkala
- Department of Future
Technologies, University of Turku, Vesilinnantie 5, FI-20500 Turku, Finland
| | - Clare J. Strachan
- Division of Pharmaceutical
Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, FI-00790 Helsinki, Finland
| |
Collapse
|
17
|
Lipiäinen T, Fraser-Miller SJ, Gordon KC, Strachan CJ. Direct comparison of low- and mid-frequency Raman spectroscopy for quantitative solid-state pharmaceutical analysis. J Pharm Biomed Anal 2018; 149:343-350. [DOI: 10.1016/j.jpba.2017.11.013] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2017] [Revised: 10/27/2017] [Accepted: 11/01/2017] [Indexed: 10/18/2022]
|
18
|
Lai F, Du JJ, Williams PA, Váradi L, Baker D, Groundwater PW, Overgaard J, Platts JA, Hibbs DE. A comparison of the experimental and theoretical charge density distributions in two polymorphic modifications of piroxicam. Phys Chem Chem Phys 2018; 18:28802-28818. [PMID: 27722530 DOI: 10.1039/c6cp02690g] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Experimental charge density distribution studies of two polymorphic forms of piroxicam, β-piroxicam (1) and piroxicam monohydrate (2), were carried out via high-resolution single crystal X-ray diffraction experiments and multipole refinement. The asymmetric unit of (2) consists of two discrete piroxicam molecules, (2a) and (2b), and two water molecules. Geometry differs between (1) and (2) due to the zwitterionic nature of (2) which results in the rotation of the pyridine ring around the C(10)-N(2) bond by approximately 180°. Consequently, the pyridine and amide are no longer co-planar and (2) forms two exclusive, strong hydrogen bonds, H(3)O(4) and H(2)O(3), with bond energies of 66.14 kJ mol-1 and 112.82 kJ mol-1 for (2a), and 58.35 kJ mol-1 and 159.51 kJ mol-1 for (2b), respectively. Proton transfer between O(3) and N(3) in (2) results in significant differences in surface electrostatic potentials. This is clarified by the calculation of atomic charges in the zwitterion that shows the formally positive charge of the pyridyl nitrogen which is redistributed over the whole of the pyridine ring instead of concentrating at N-H. Similarly, the negative charge of the oxygen is distributed across the benzothiazine carboxamide moiety. The multipole derived lattice energy for (1) is -304 kJ mol-1 and that for (2) is -571 kJ mol-1, which is in agreement with the experimentally determined observations of higher solubility and dissolution rates of (1) compared to (2).
Collapse
Affiliation(s)
- Felcia Lai
- Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia.
| | - Jonathan J Du
- Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia.
| | - Peter A Williams
- Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia. and School of Science and Health, Western Sydney University, Locked Bag 1797, Penrith, NSW 2751, Australia
| | - Linda Váradi
- Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia.
| | - Daniel Baker
- Rigaku Oxford Diffraction, Oxford Industrial Park, Yarnton, Oxfordshire, OX5 1QU, UK
| | | | - Jacob Overgaard
- Department of Chemistry, Center for Materials Crystallography, Aarhus University, Langelandsgade 140, Aarhus C, 8000, Denmark
| | - James A Platts
- School of Chemistry, Cardiff University, P.O. Box 912, Cardiff, CF13TB, Wales, UK
| | - David E Hibbs
- Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia.
| |
Collapse
|
19
|
Recent progress of structural study of polymorphic pharmaceutical drugs. Adv Drug Deliv Rev 2017; 117:71-85. [PMID: 27940141 DOI: 10.1016/j.addr.2016.12.001] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2016] [Revised: 12/02/2016] [Accepted: 12/06/2016] [Indexed: 12/20/2022]
Abstract
This review considers advances in the understanding of active pharmaceutical ingredient polymorphism since around 2010 mainly from a structural view point, with a focus on twelve model drugs. New polymorphs of most of these drugs have been identified despite that the polymorphism of these old drugs has been extensively studied so far. In addition to the conventional modifications of preparative solvents, temperatures, and pressure, more strategic structure-based methods have successfully yielded new polymorphs. The development of analytical techniques, including X-ray analyses, spectroscopy, and microscopy has facilitated the identification of unknown crystal structures and also the discovery of new polymorphs. Computational simulations have played an important role in explaining and predicting the stability order of polymorphs. Furthermore, these make significant contributions to the design of new polymorphs by considering structure and energy. The new technologies and insights discussed in this review will contribute to the control of polymorphic forms, both during manufacture and in the drug formulation.
Collapse
|